{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P12034",
      "entity_text" : "FGF5",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "CellLine" : [ "cellosaurus:CVCL_7025" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Results of the present study suggest that patients in the FGF5 high expression group had better clinicopathological features (including histopathological grading, clinical risk group according to St Gallen criteria, clinical risk group according to NPI criteria, and clinical risk group according to Veridex signature) relative to those in the FGF5 low expression group, indicating that higher expression of FGF5 predicts better prognosis of patients with BC.",
  "reading_complete" : "2020-08-04T15:47:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T15:44:43Z",
  "trigger" : "expression",
  "evidence" : [ "expression of FGF5" ],
  "pmc_id" : "5998728",
  "score" : 0
}